BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22369180)

  • 21. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
    Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
    Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes.
    Jiang F; Richter J; Schraml P; Bubendorf L; Gasser T; Sauter G; Mihatsch MJ; Moch H
    Am J Pathol; 1998 Nov; 153(5):1467-73. PubMed ID: 9811338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virtual-karyotyping with SNP microarrays in morphologically challenging renal cell neoplasms: a practical and useful diagnostic modality.
    Kim HJ; Shen SS; Ayala AG; Ro JY; Truong LD; Alvarez K; Bridge JA; Gatalica Z; Hagenkord JM; Gonzalez-Berjon JM; Monzon FA
    Am J Surg Pathol; 2009 Sep; 33(9):1276-86. PubMed ID: 19461508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of aneuploidy in stage IV clear cell renal cell carcinoma revealed by comparative genomic hybridization and spectral karyotyping.
    Pavlovich CP; Padilla-Nash H; Wangsa D; Nickerson ML; Matrosova V; Linehan WM; Ried T; Phillips JL
    Genes Chromosomes Cancer; 2003 Jul; 37(3):252-60. PubMed ID: 12759923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biphasic alveolosquamoid renal carcinoma: a histomorphological, immunohistochemical, molecular genetic, and ultrastructural study of a distinctive morphologic variant of renal cell carcinoma.
    Petersson F; Bulimbasic S; Hes O; Slavik P; Martínek P; Michal M; Gomolčáková B; Hora M; Damjanov I
    Ann Diagn Pathol; 2012 Dec; 16(6):459-69. PubMed ID: 23036259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype.
    Kammerer-Jacquet SF; Brunot A; Pladys A; Bouzille G; Dagher J; Medane S; Peyronnet B; Mathieu R; Verhoest G; Bensalah K; Edeline J; Laguerre B; Lespagnol A; Mosser J; Dugay F; Belaud-Rotureau MA; Rioux-Leclercq N
    Clin Genitourin Cancer; 2017 Feb; 15(1):e1-e7. PubMed ID: 27444986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
    Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
    Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.
    Tickoo SK; dePeralta-Venturina MN; Harik LR; Worcester HD; Salama ME; Young AN; Moch H; Amin MB
    Am J Surg Pathol; 2006 Feb; 30(2):141-53. PubMed ID: 16434887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Papillary renal cell carcinoma: quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy.
    Corless CL; Aburatani H; Fletcher JA; Housman DE; Amin MB; Weinberg DS
    Diagn Mol Pathol; 1996 Mar; 5(1):53-64. PubMed ID: 8919546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xp11.2 translocation renal neoplasm with features of TFE3 rearrangement associated renal cell carcinoma and Xp11 translocation renal mesenchymal tumor with melanocytic differentiation harboring NONO-TFE3 fusion gene.
    Yu W; Wang Y; Rao Q; Jiang Y; Zhang W; Li Y
    Pathol Res Pract; 2019 Sep; 215(9):152521. PubMed ID: 31277953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of tubulocystic carcinoma simultaneously occurring with clear cell type renal cell carcinoma and micropapillary urothelial carcinoma of bladder.
    Gönül II; Cakr A; Sözen S; Ataoglu O; Alkibay T
    South Med J; 2009 Jul; 102(7):754-7. PubMed ID: 19488016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience.
    Klatte T; Wunderlich H; Patard JJ; Kleid MD; Lam JS; Junker K; Schubert J; Böhm M; Allhoff EP; Kabbinavar FF; Crepel M; Cindolo L; De La Taille A; Tostain J; Mejean A; Soulie M; Bellec L; Bernhard JC; Ferriere JM; Pfister C; Albouy B; Colombel M; Zisman A; Belldegrun AS; Pantuck AJ
    BJU Int; 2007 Jul; 100(1):21-5. PubMed ID: 17433034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic alterations in renal cell carcinoma with rhabdoid differentiation.
    Perrino CM; Hucthagowder V; Evenson M; Kulkarni S; Humphrey PA
    Hum Pathol; 2015 Jan; 46(1):9-16. PubMed ID: 25439741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
    Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L
    Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
    Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal cell carcinomas with t(6;11)(p21;q12) presenting with tubulocystic renal cell carcinoma-like features.
    Rao Q; Zhang XM; Tu P; Xia QY; Shen Q; Zhou XJ; Shi QL
    Int J Clin Exp Pathol; 2013; 6(7):1452-7. PubMed ID: 23826432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tubulocystic renal cell carcinoma with poorly differentiated foci is indicative of aggressive behavior: clinicopathologic study of two cases and review of the literature.
    Zhao M; Teng X; Ru G; Zhao Z; Hu Q; Han L; He X
    Int J Clin Exp Pathol; 2015; 8(9):11124-31. PubMed ID: 26617832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of two synchronous histologically different renal cell carcinoma subtypes in the same kidney: a case report and review of the literature.
    Sakr M; Badran M; Hassan SA; Elsaqa M; Elwany MA; Deeb NMFE; Sharafeldeen M
    J Med Case Rep; 2024 May; 18(1):250. PubMed ID: 38760853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.
    Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O
    Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.